Treatment of multiple sclerosis continues to evolve. New understandings occur about old drugs and new drugs are released. In this chapter we provide an overview of treatment in MS. We review the long-standing FDA approved therapies including the injectables and Tysabri. We then turn toward ...
Schreiner, B.et al. Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.J. Neuroimmunol.155, 172–182 (2004). ArticleCASPubMedGoogle Scholar Comabella...
Multiple Sclerosis. An Ancient Chinese Fungus Becomes an Oral Medication for Multiple Sclerosis.An Ancient Chinese Fungus Becomes an Oral Medication for Multiple Sclerosis.The article reports on the approval of ancient Chinese fungus fingolimod by the Food and Drug Administration (FDA) in the U.S. ...
In an interview with Pharmacy Times, Megan Scheider, PharmD, discussed pharmacists’ role in addressing medication adherence for patients with multiple sclerosis (MS). Understanding patients’ specific experiences and challenges is crucial to helping them improve medication adherence.Q...
New research raises questions about the efficacy of one of the most commonly prescribed drugs used to treat relapsing-remitting multiple sclerosis. Although the immunomodulator interferon beta is recognized as a standard treatment for relapsing-remitting multiple sclerosis (MS) and is thought to reduce ...
A decade after UC San Francisco scientists identified an over-the-counter antihistamine as a treatment for multiple sclerosis, researchers have developed an approach to measure the drug's effectiveness in repairing the brain, making it possible to also a
Multiple sclerosis (MS) is one of the most studied neurological diseases, although scarce attention has been placed on symptomatic therapy. The aim of the study was to evaluate the frequency of medication prescription for the major symptoms related to MS in order to better understand the needs of...
Medication can help to manage attacks, reduce symptoms, and slow the progression ofmultiple sclerosis. According to the NMSS, some people stop taking disease-modifying medication for reasons including side effects, perceptions they're not feeling better or because they still experience exacerbations, or...
Multiple sclerosis, DMT, disease modifying therapy, adherenceBackground: Multiple sclerosis (MS), a debilitating, chronic disease of the central nervous system, is the most common cause of neurological defects in young adults. There are currently over a dozen disease-modifying therapies (DMTs) that...
for customized information Have you or your loved one been switched to a generic from COPAXONE®? YesNo Change my answer Get Back on COPAXONE®! Learn how COPAXONE®may help improve your multiple sclerosis (MS)! COPAXONE®EffectivenessFind Affordable AccessExplore MS Resources ...